Pyrazolone derivatives can inhibit the receptors of the tyrosine kinase c-mesenchymal–epithelial transition (c-Met)/vascular endothelial growth factor receptor 2 (VEGFR-2) [30] or induce apoptosis and inhibit the proliferation of cancer cells [31], which makes them promising for cancer therapy. The gene discussed is KDR; the disease is cancer.